Seizures Common in Hospitalized COVID-19 Patients
Seizures Common in Hospitalized COVID-19 Patients
The death rate was higher among those who experienced the seizures, according to a study conducted during the early days of the pandemic.
Seizures Common in Hospitalized COVID-19 Patients
Seizures Common in Hospitalized COVID-19 Patients

The death rate was higher among those who experienced the seizures, according to a study conducted during the early days of the pandemic.

The death rate was higher among those who experienced the seizures, according to a study conducted during the early days of the pandemic.

coronavirus
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Jef Akst | Apr 9, 2021
Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
Shawna Williams | Apr 9, 2021
Vaccinations with the Johnson & Johnson jab paused at several sites earlier this week after an unusual number of people experienced adverse reactions, but the CDC says there’s no cause for concern.
How Infectious Diseases Affect the Brain
How Infectious Diseases Affect the Brain
The Scientist Creative Services Team | Apr 8, 2021
From a loss of taste to dementia, infectious agents cause an array of neurological symptoms.
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Catherine Offord | Apr 8, 2021
The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.
Using Multicolor Flow Cytometry for COVID-19 Research
Using Multicolor Flow Cytometry for COVID-19 Research
The Scientist Creative Services Team | Apr 8, 2021
Designing multicolor flow cytometry panels to characterize immunological changes observed in COVID-19 patients.
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Kerry Grens | Apr 7, 2021
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine
Lisa Winter | Apr 6, 2021
Stanford University researchers determined the code from spare drops in discarded vials of the COVID-19 vaccine and published it on GitHub.
Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
Rachael Moeller Gorman | Apr 1, 2021
Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.
Pfizer Vaccine Induces Immune Structures Key to Lasting Immunity
Pfizer Vaccine Induces Immune Structures Key to Lasting Immunity
Katarina Zimmer | Mar 25, 2021
In the armpit lymph nodes of people who had received the mRNA vaccine against SARS-CoV-2, researchers found germinal centers needed to generate long-lived antibody-making cells.